NextCure, Inc.NXTCNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank38
3Y CAGR-0.8%
5Y CAGR-4.5%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-0.8%/yr
vs -33.4%/yr prior
5Y CAGR
-4.5%/yr
Recent acceleration
Acceleration
+32.6pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
2025$25.98M-6.3%
2024$27.73M+111.9%
2023$13.08M-50.9%
2022$26.63M+115.9%
2021$12.34M-62.4%
2020$32.77M-3.9%
2019$34.09M-74.8%
2018$135.17M+1504.0%
2017$8.43M-